Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 TrialFederico Pulido, M. A. von Wichmann, Esteban Ribera et al.|Clinical Infectious Diseases|2017Cited by 103
Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)Sergio Serrano‐Villar, Vicente Estrada, María Lagarde et al.|Clinical Infectious Diseases|2018Cited by 62
Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018Marta Rava, Inmaculada Jarrín, Lourdes Domínguez et al.|PLoS ONE|2021Cited by 48
Late presentation for HIV impairs immunological but not virological response to antiretroviral treatmentMarta Rava, Inmaculada Jarrín, Otilia Bisbal et al.|AIDS|2021Cited by 27
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune RecoverySergio Serrano‐Villar, Manuel Ferrer, Sergio Sánchez-Carrillo et al.|The Journal of Infectious Diseases|2020Cited by 20